HBV
Clinical trials for HBV explained in plain language.
Never miss a new study
Get alerted when new HBV trials appear
Sign up with your email to follow new studies for HBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hepatitis b: experimental drug Tune-401 enters human testing
Disease control Recruiting nowThis early-stage study tests the safety of a new drug, Tune-401, in 36 adults with chronic hepatitis B. Participants must already be on standard antiviral therapy. The main goal is to see if the drug is safe and how the body processes it. This is not a cure, but a step toward bet…
Matched conditions: HBV
Phase: PHASE1 • Sponsor: Tune Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 06:40 UTC
-
Single test could detect HIV, hepatitis, and syphilis in minutes
Diagnosis Recruiting nowThis study evaluates a new point-of-care device called MagIA H3S that can test for HIV, hepatitis B, hepatitis C, and syphilis from a single blood sample. Researchers will enroll about 2,950 people in Ivory Coast and Kenya to see how accurate the device is compared to standard la…
Matched conditions: HBV
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC
-
New study tracks hidden risks of hepatitis b drugs in vulnerable patients
Knowledge-focused Recruiting nowThis study follows 490 adults with a past hepatitis B infection who need immune-suppressing treatments. Researchers will monitor bone, kidney, and metabolic health over 4 years to understand the long-term effects of antiviral drugs. The goal is to create better safety guidelines …
Matched conditions: HBV
Sponsor: Yaşar Bayındır, MD • Aim: Knowledge-focused
Last updated May 17, 2026 06:40 UTC
-
Gut check: new study probes how hepatitis drug changes your microbiome
Knowledge-focused Recruiting nowThis study tracks 20 adults with chronic hepatitis delta (a serious liver infection) who are starting a new drug called bulevirtide. Researchers want to see how the drug changes the gut's bacteria and bile acids over 48 weeks, and how those changes relate to inflammation and live…
Matched conditions: HBV
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
New blood test could transform care for hepatitis b and d patients
Knowledge-focused Recruiting nowThis study aims to create a rapid test that measures T-cell responses in people with chronic hepatitis B (HBV) or combined hepatitis B and D (HBV/HDV). By analyzing immune system activity, researchers hope to better understand how the disease progresses and how patients respond t…
Matched conditions: HBV
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC